Functional Roles of Epitranscriptomic Marks in the Cardiovascular System and Disease: a Narrative Review

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2022 Aug 12

PMID 35957723

Authors

Mirolyuba Ilieva

Shizuka Uchida

Affiliations

Soon will be listed here.

Abstract

Background And Objective: The recent emergence of epitranscriptomics provides an avenue for identifying RNA modifications implicated in the pathophysiology of human disease. To date, over 170 RNA modifications have been identified; these modifications are important because they can affect the fate of RNAs, including their decay, maturation, splicing, stability, and translational efficiency. Although RNA modifications have been reported in many tissues and disease contexts, detailed functional studies in the heart and cardiovascular disease are only beginning to be reported.

Methods: The search for relevant articles related to epitranscriptomics was conducted by focusing on the cardiovascular system and disease in the PubMed database.

Key Content And Findings: We summarize the recent findings of three epitranscriptomic marks-N6-methyladenosine (mA), adenosine to inosine (A-to-I) RNA editing, and 5-methylcytosine (mC) as other epitranscriptomic marks are not studied extensively in the cardiovascular system and disease.

Conclusions: In this narrative review, the current status of cardiac epitranscriptomics is summarized to raise the awareness of this important field of study.

Citing Articles

The Epitranscriptomic Mechanism of Metal Toxicity and Carcinogenesis.

Yang C, Wang Z Int J Mol Sci. 2022; 23(19).

PMID: 36233132 PMC: 9569618. DOI: 10.3390/ijms231911830.

References

Mauer J, Jaffrey S . FTO, m A , and the hypothesis of reversible epitranscriptomic mRNA modifications. FEBS Lett. 2018; 592(12):2012-2022. DOI: 10.1002/1873-3468.13092. View

Hinger S, Wei J, Dorn L, Whitson B, Janssen P, He C . Remodeling of the mA landscape in the heart reveals few conserved post-transcriptional events underlying cardiomyocyte hypertrophy. J Mol Cell Cardiol. 2020; 151:46-55. PMC: 7880874. DOI: 10.1016/j.yjmcc.2020.11.002. View

Plikus M, Wang X, Sinha S, Forte E, Thompson S, Herzog E . Fibroblasts: Origins, definitions, and functions in health and disease. Cell. 2021; 184(15):3852-3872. PMC: 8566693. DOI: 10.1016/j.cell.2021.06.024. View

Wang Q, Miyakoda M, Yang W, Khillan J, Stachura D, Weiss M . Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem. 2003; 279(6):4952-61. DOI: 10.1074/jbc.M310162200. View

Mathiyalagan P, Adamiak M, Mayourian J, Sassi Y, Liang Y, Agarwal N . FTO-Dependent N-Methyladenosine Regulates Cardiac Function During Remodeling and Repair. Circulation. 2018; 139(4):518-532. PMC: 6400591. DOI: 10.1161/CIRCULATIONAHA.118.033794. View

Uchida S, Dimmeler S . Long noncoding RNAs in cardiovascular diseases. Circ Res. 2015; 116(4):737-50. DOI: 10.1161/CIRCRESAHA.116.302521. View

Moses K, DeMayo F, Braun R, Reecy J, Schwartz R . Embryonic expression of an Nkx2-5/Cre gene using ROSA26 reporter mice. Genesis. 2002; 31(4):176-80. DOI: 10.1002/gene.10022. View

Litvinukova M, Talavera-Lopez C, Maatz H, Reichart D, Worth C, Lindberg E . Cells of the adult human heart. Nature. 2020; 588(7838):466-472. PMC: 7681775. DOI: 10.1038/s41586-020-2797-4. View

Uchida S, Jones S . RNA Editing: Unexplored Opportunities in the Cardiovascular System. Circ Res. 2018; 122(3):399-401. PMC: 5808601. DOI: 10.1161/CIRCRESAHA.117.312512. View

10.

Frayling T, Timpson N, Weedon M, Zeggini E, Freathy R, Lindgren C . A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316(5826):889-94. PMC: 2646098. DOI: 10.1126/science.1141634. View

11.

Rice G, Kasher P, Forte G, Mannion N, Greenwood S, Szynkiewicz M . Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet. 2012; 44(11):1243-8. PMC: 4154508. DOI: 10.1038/ng.2414. View

12.

Ehrenhofer-Murray A . Cross-Talk between Dnmt2-Dependent tRNA Methylation and Queuosine Modification. Biomolecules. 2017; 7(1). PMC: 5372726. DOI: 10.3390/biom7010014. View

13.

Su X, Shen Y, Jin Y, Kim I, Weintraub N, Tang Y . Aging-Associated Differences in Epitranscriptomic m6A Regulation in Response to Acute Cardiac Ischemia/Reperfusion Injury in Female Mice. Front Pharmacol. 2021; 12:654316. PMC: 8369344. DOI: 10.3389/fphar.2021.654316. View

14.

Stellos K, Gatsiou A, Stamatelopoulos K, Matic L, John D, Lunella F . Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation. Nat Med. 2016; 22(10):1140-1150. DOI: 10.1038/nm.4172. View

15.

Payne S, De Val S, Neal A . Endothelial-Specific Cre Mouse Models. Arterioscler Thromb Vasc Biol. 2018; 38(11):2550-2561. PMC: 6218004. DOI: 10.1161/ATVBAHA.118.309669. View

16.

Xue C, Zhao Y, Li L . Advances in RNA cytosine-5 methylation: detection, regulatory mechanisms, biological functions and links to cancer. Biomark Res. 2020; 8:43. PMC: 7490858. DOI: 10.1186/s40364-020-00225-0. View

17.

Yang Y, Hsu P, Chen Y, Yang Y . Dynamic transcriptomic mA decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018; 28(6):616-624. PMC: 5993786. DOI: 10.1038/s41422-018-0040-8. View

18.

Grosset C, Chen C, Xu N, Sonenberg N, Jacquemin-Sablon H, Shyu A . A mechanism for translationally coupled mRNA turnover: interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex. Cell. 2000; 103(1):29-40. DOI: 10.1016/s0092-8674(00)00102-1. View

19.

Esteller M, Pandolfi P . The Epitranscriptome of Noncoding RNAs in Cancer. Cancer Discov. 2017; 7(4):359-368. PMC: 5997407. DOI: 10.1158/2159-8290.CD-16-1292. View

20.

Lazar E, Sadek H, Bergmann O . Cardiomyocyte renewal in the human heart: insights from the fall-out. Eur Heart J. 2017; 38(30):2333-2342. PMC: 5837331. DOI: 10.1093/eurheartj/ehx343. View